Your browser doesn't support javascript.
loading
Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features.
Durcan, Emre; Keskin, Fatma Ela; Ozkaya, Hande Mefkure; Sirolu, Sabri; Sahin, Serdar; Korkmaz, Ozge Polat; Gazioglu, Nurperi; Tanriover, Necmettin; Comunoglu, Nil; Oz, Buge; Kizilkilic, Osman; Kadioglu, Pinar.
Afiliación
  • Durcan E; Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Keskin FE; Division of Endocrinology and Metabolism, Department of Internal Medicine, T.C. Demiroglu Bilim University, Istanbul, Turkey.
  • Ozkaya HM; Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Sirolu S; Department of Radiodiagnostic, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Sahin S; Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Korkmaz OP; Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Gazioglu N; Department of Neurosurgery, T.C. Demiroglu Bilim University, Istanbul, Turkey.
  • Tanriover N; Department of Neurosurgery, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Comunoglu N; Department of Pathology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Oz B; Department of Pathology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Kizilkilic O; Department of Radiodiagnostic, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Kadioglu P; Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Exp Clin Endocrinol Diabetes ; 130(2): 125-133, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34255320
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Biomarcadores de Tumor / Adenoma / Receptor Tipo 4 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Clin Endocrinol Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Biomarcadores de Tumor / Adenoma / Receptor Tipo 4 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Clin Endocrinol Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Alemania